Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Operating Expenses | 12,520 | 12,149 | 11,877 | 9,536 | 8,182 |
| Operating Income | -12,520 | -12,149 | -11,877 | -9,536 | -8,182 |
| Other Income | 944 | 870 | 364 | 278 | 232 |
| Pre-tax Income | -11,575 | -11,279 | -11,513 | -9,258 | -7,950 |
| Net Income Continuous | -11,575 | -11,279 | -11,513 | -9,258 | -7,950 |
| Net Income | $-11,575 | $-11,279 | $-11,513 | $-9,258 | $-7,950 |
| EPS Basic Total Ops | -27.00 | -26.00 | -33.00 | -25.00 | -24.00 |
| EPS Basic Continuous Ops | -26.88 | -26.35 | -32.75 | -25.25 | -24.29 |
| EPS Diluted Total Ops | -27.00 | -26.00 | -33.00 | -25.00 | -24.00 |
| EPS Diluted Continuous Ops | -26.88 | -26.35 | -32.75 | -25.25 | -24.29 |
| EBITDA(a) | $-12,451 | $-12,079 | $-11,808 | $-9,466 | $-8,112 |